Skip to content

Reimagining the infrastructure of cancer care

Clinicians, researchers, and regulators rely on Flatiron technology and evidence to learn faster and power smarter care for every patient. Because transforming cancer care takes all of us.

Expanding the possibilities for point of care solutions in oncology

Point of care

We’re partnering with cancer centers to deliver a better patient experience, strengthen practice health, and close the gap between care and research.

Realizing the full potential of real-world evidence in oncology

Real-world evidence

With Flatiron’s integrated RWE solutions, our customers are harnessing new approaches to evidence generation through our engaged care network, oncology-specific expertise, and fit-for-purpose scientific methods and tools.

Bridging the gap between care and research

Clinical research

We’re transforming clinical research through technology that seamlessly integrates into everyday patient care.

Transforming global oncology care and research


We’re accelerating cancer research and improving the quality of care globally, using real-world evidence to improve patient outcomes, inform policy, and advance research.

Hear from our customers

With Flatiron Assist™ surfacing and prioritizing appropriate regimens for physicians, based on key clinical and prognostic factors, we are driving value with every treatment decision.

Olivia Barrett Healthcare Business Analyst, Hematology Oncology Associates of Central New York

Flatiron was chosen because it’s fit-for-purpose. You have the right population and good sample size. Unstructured data covers the primary endpoint of the trial, which is overall response rate. A key learning is you need to choose a database that is fit-for-purpose with good quality.

H. Mark Lin, PhD Senior Director, Global Evidence and Outcome Research in Oncology at Takeda

Source: ResearchX

Working with partners like Flatiron and technology like [Flatiron] Clinical Pipe™ and Flatiron Vessel™ has been an excellent opportunity for us to really build processes and systems around the technology that is available today and get those technologies to work together.

Dannelle M. Palmer, MBA, PMP Chief Operating Officer, OncoBay Clinical

Flatiron Clinical Research Presence at DPHARM 2023

DPHARM 2023 highlights the latest innovations in clinical trials that are driving efficiencies in clinical operations and reducing burden to participate in research. Join Flatiron at booth #39 to learn more about how we are innovating in clinical trials.
Sep 20–22, 2023
Boston, Massachusetts
Visit website

Who we are

Our mission is to improve and extend lives by learning from the experience of every person with cancer.



3.5 million+

Patient records available for research


Flatiron data has been featured in 500+ publications

Be the next changemaker in cancer care

Reimagine the infrastructure of cancer care with a community that values integrity, inspires growth, and is uniquely positioned to create a more modern, connected oncology ecosystem.

Get started with Flatiron